Vitro Biopharma, Inc. (VTRO)

Vitro Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Year Ending	Current	Oct 31, 2021	Oct 31, 2020
Market Capitalization	40	-	-
Enterprise Value	41	-	-
Debt / Equity Ratio	0.47	1.83	-1.22
Debt / EBITDA Ratio	-0.64	-1.50	-2.69
Debt / FCF Ratio	-1.72	-6.12	-3.98
Quick Ratio	2.54	3.16	0.81
Interest Coverage	-15.14	-10.75	-4.57
Return on Equity (ROE)	-66.16%	-130.89%	59.51%
Return on Assets (ROA)	-	-40.63%	-152.39%
Return on Capital (ROIC)	-33.98%	-42.17%	-219.20%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).